Table 1 Age and sex distribution of studied groups
From: Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
| Â | PsA (n = 40) | Psoriasis without arthritis (n = 40) | RA (n = 40) | Healthy controls (n = 40) |
|---|---|---|---|---|
Age (years) | Â | Â | Â | Â |
Mean ± SD | 42.85 ± 6 | 43 ± 4 | 46.9 ± 5 | 40 ± 4 |
Sex | Â | Â | Â | Â |
Males n(%) | 18(45%) | 26 (65%) | 9 (22.5%) | 16 (40%) |
Females n(%) | 22 (55%) | 14 (35%) | 31 (77.5%) | 24 (60%) |